Charles’s Journey with Small Cell Lung Cancer

  Рет қаралды 7,023

Amgen

Amgen

Жыл бұрын

Patient Points of View is a video series bringing individual stories to life by highlighting the uniqueness of each patient’s experience navigating their cancer journey.
In this video, Charles shares his experience of receiving a small cell lung cancer diagnosis and the impact on his mental health. Despite the incurable nature of his disease, treatment offered hope and optimism for the future.
Sadly, Charles lost his battle with small cell lung cancer in May 2023. We extend our deepest appreciation to Charles’s family and friends for allowing us to share his story.
Explore other patient points of view: • Patient Points of View
Learn more about Amgen Oncology:
www.amgenoncology.com/
Find Amgen Oncology on the Web:
Twitter: bit.ly/3nGSj6Y
LinkedIn: bit.ly/3MhCe10
#cancer #cancerpatient #patientstory #patientexperience #chemotherapy #immunotherapy #mentalhealth #cancersurvivor #smallcelllungcancer #sclc
© 2023 Amgen, Inc. All rights reserved.
Find Amgen on the Web:
Facebook: bit.ly/35Xf09E
Instagram: bit.ly/2SYnTKJ
Twitter: bit.ly/2SW2cLq
LinkedIn: bit.ly/2xWbS17

Пікірлер
Pamela’s Small Cell Lung Cancer Story
4:11
Amgen
Рет қаралды 19 М.
Deborah’s Experience with Non-Small Cell Lung Cancer
3:52
small vs big hoop #tiktok
00:12
Анастасия Тарасова
Рет қаралды 18 МЛН
Haha😂 Power💪 #trending #funny #viral #shorts
00:18
Reaction Station TV
Рет қаралды 14 МЛН
Please be kind🙏
00:34
ISSEI / いっせい
Рет қаралды 169 МЛН
Lindy’s Experience with Small Cell Lung Cancer
2:40
Amgen
Рет қаралды 7 М.
Gina’s Colorectal Cancer Story
3:23
Amgen
Рет қаралды 15 М.
Gwen’s Fight with Non-Small Cell Lung Cancer
2:58
Amgen
Рет қаралды 5 М.
Хотела заскамить на Айфон!😱📱(@gertieinar)
0:21
Взрывная История
Рет қаралды 3,8 МЛН
iOS 18 vs Samsung, Xiaomi,Tecno, Android
0:54
AndroHack
Рет қаралды 85 М.
Hisense Official Flagship Store Hisense is the champion What is going on?
0:11
Special Effects Funny 44
Рет қаралды 1,8 МЛН
Iphone or nokia
0:15
rishton vines😇
Рет қаралды 1,9 МЛН